Stock NGNE NEUROGENE INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Strategies Neurogene Inc.

Equities

NGNE

US64135M1053

Real-time Estimate Cboe BZX
Other stock markets
 02:35:59 2024-05-09 pm EDT 		5-day change 1st Jan Change
33.28 USD +1.14% Intraday chart for Neurogene Inc. -5.37% +72.81%
May. 07 Neurogene Presents Favorable Safety Data from Phase 1/2 Trial of Ngn-401 Gene Therapy for Rett Syndrome During Asgct Annual Meeting CI
Apr. 29 Leerink Partners Starts Neurogene With Outperform Rating, $46 Price Target MT

MarketScreener Strategies

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NGNE Stock
  4. News Neurogene Inc.
  5. MarketScreener Strategies
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW